HPAPI Growth Fermion specializes in high potent API manufacturing with capabilities from grams to tons and closed handling systems, presenting a strong opportunity to partner with pharma companies seeking HPAPI development and scale-up without transfer costs.

Expansion Footprint Recent and ongoing facility expansions in Finland and Northern Europe point to increasing production capacity and regional supply reliability, ideal for customers needing closer geographic sourcing and shorter lead times.

FDA Approval Longstanding FDA approval since 1979 enhances credibility for global clients seeking compliant CDMO partners, especially for regulated markets and complex, sensitive oncology APIs.

One-stop CDMO Fermion positions as a single-source partner offering API development, manufacturing, and full-scale production with no tech transfer costs, enabling faster time-to-market and simplified supplier relationships.

Strategic Partnerships Past collaborations with Ami Organics and a track record in oncology and highly potent compounds indicate openness to co-development and supply agreements, suggesting avenues for new multi-year, multi-tonne API supplies.